NASDAQ:BBIO | Operating Income | BridgeBio Pharma, Inc.

Complete source-backed operating income history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$107.08M
2026-03-31-$105.96M
2025-12-31-$139.56M
2025-09-30-$145.2M
2025-06-30-$134.28M
2025-03-31-$104.37M
2024-12-31-$226.03M
2024-09-30-$191.75M
2024-06-30-$175.54M
2024-03-31$343,000.00
2023-12-31-$177.42M
2023-09-30-$157.69M
2023-06-30-$146.1M
2023-03-31-$126.16M
2022-12-31-$129.23M
2022-09-30-$129.12M
2022-06-30-$80.18M
2022-03-31-$173.68M
2021-12-31-$165.61M
2021-09-30-$149.5M
2021-06-30-$94.02M
2021-03-31-$167.5M
2020-12-31-$127.49M
2020-09-30-$119.94M
2020-06-30-$124.57M
2020-03-31-$102.49M
2019-12-31-$78.64M
2019-09-30-$54.53M
2019-06-30-$69.32M
2019-03-31-$63.75M
2018-12-31-$65.58M
2018-09-30-$41.46M

Annual Operating Income

DateOperating Income
2025-12-31-$523.41M
2024-12-31-$592.97M
2023-12-31-$607.37M
2022-12-31-$512.2M
2021-12-31-$576.63M
2020-12-31-$474.48M
2019-12-31-$266.24M
2018-12-31-$183.66M
2017-12-31-$43.86M